254 related articles for article (PubMed ID: 33471204)
1. The Management of Penile Fracture: a Review of the Literature with Special Consideration for Patients Undergoing Collagenase Clostridium Histolyticum Injection Therapy.
Hughes WM; Natale C; Hellstrom WJG
Curr Urol Rep; 2021 Jan; 22(2):13. PubMed ID: 33471204
[TBL] [Abstract][Full Text] [Related]
2. Intralesional Injection of Collagenase Clostridium histolyticum May Increase the Risk of Late-Onset Penile Fracture.
Beilan JA; Wallen JJ; Baumgarten AS; Morgan KN; Parker JL; Carrion RE
Sex Med Rev; 2018 Apr; 6(2):272-278. PubMed ID: 28923562
[TBL] [Abstract][Full Text] [Related]
3. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
[TBL] [Abstract][Full Text] [Related]
4. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
5. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
6. Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.
Yousif A; Natale C; Hellstrom WJG
Curr Urol Rep; 2021 Jan; 22(2):6. PubMed ID: 33420664
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.
Bazzi M; Jamil ML; Dabaja AA
Curr Urol Rep; 2019 Jun; 20(8):42. PubMed ID: 31201571
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Sukumar S; Pijush DB; Brandes S
J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
10. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
El-Khatib FM; Towe M; Yafi FA
World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
[TBL] [Abstract][Full Text] [Related]
11. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
12. Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie's disease.
Gannon MK; Pearlman AM
BMC Urol; 2021 Jun; 21(1):94. PubMed ID: 34176473
[TBL] [Abstract][Full Text] [Related]
13. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Natale C; McLellan DM; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
[TBL] [Abstract][Full Text] [Related]
14. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
[TBL] [Abstract][Full Text] [Related]
15. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Gabrielson AT; Spitz JT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
[TBL] [Abstract][Full Text] [Related]
16. Managing complications of collagenase Clostridium histolyticum (CCH) injection.
Greear GM; Koprowski CJ; Hsieh TC
World J Urol; 2020 Feb; 38(2):287-292. PubMed ID: 31123850
[TBL] [Abstract][Full Text] [Related]
17. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
Dhillon S
Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
[TBL] [Abstract][Full Text] [Related]
18. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
